Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.
Financial Results:
Sun Pharma Advanced Research Company Ltd reported Revenues for Q3FY24 of ₹14.00 Crores down from ₹131.00 Crore year on year, a fall of 89.31%.
Total Expenses for Q3FY24 of ₹119.00 Crores down from ₹121.00 Crores year on year, a fall of 1.65%.
Consolidated Net Profit of -₹100.00 Crores from ₹10.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹3.07, from ₹0.37 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.